Oral ANAVEX 2-73: Phase IIa started

Anavex began an open-label, crossover, Australian Phase IIa trial to evaluate oral and IV ANAVEX 2-73

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE